AstraZeneca Chairman Warns: Drug Tariffs Will Be Detrimental to Patients

In a striking statement, the chairman of AstraZeneca, Pascal Soriot, has raised alarms about the potential impact of proposed tariffs on medications, emphasizing that such measures would ultimately hurt patients in need of essential drugs. Speaking at an exclusive event, Soriot outlined the serious consequences that tariffs could impose on the pharmaceutical supply chain and healthcare access.

Continue reading